Trial intelligence / Profile preview

PTQX granules for relapse prevention in pediatric atopic dermatitis

ChiCTR-TRC-12003174Phase 2Completed

Sponsor
Guangdong Provincial Hospital of Traditional Chinese Medicine
Start
Mar 2013
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of Pei Tu Qing Xin in atopic dermatitis (AD) (2 arms), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: Cumulative remission time. Started Mar 2013; status: completed.

02

Drugs

Pei Tu Qing Xin
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on ChiCTR-TRC-12003174.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-12003174.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call